Skip to main content
Clinical Trials/EUCTR2008-006846-24-GB
EUCTR2008-006846-24-GB
Active, not recruiting
Phase 1

An Evaluation of the Effectiveness of Ibuprofen and Morphine for Acute Pain in Sickle Cell Disease - Ibuprofen and Morphine for Acute Sickle Cell Pain

orth West London Hospitals NHS Trust0 sites320 target enrollmentDecember 12, 2008

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Sickle Cell Disease
Sponsor
orth West London Hospitals NHS Trust
Enrollment
320
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 12, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
orth West London Hospitals NHS Trust

Eligibility Criteria

Inclusion Criteria

  • Adult patients with SCD of any phenotype and gender aged 16 years and over
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • 1\. Patient has a history of allergic reaction to either morphine or ibuprofen
  • 2\. Patient has contraindications to morphine or ibuprofen, e.g. peptic ulcer disease, NSAID\-induced asthma
  • 3\. Patient in a drug dependency programme
  • 4\. Patient is on renal dialysis
  • 5\. Stroke within the last 6 weeks
  • 6\. Platelet count \< 50 X 10E9/l
  • 7\. Patient is pregnant or breastfeeding
  • 8\. Doctor unwilling to randomise the patient for other reasons
  • 9\. Previous participation in the trial

Outcomes

Primary Outcomes

Not specified

Similar Trials